SCHEMBL5704384

SCHEMBL5704384

N#Cc1c(Cl)c(N)cc(F)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
KHK P50053 1/20 0.39
TRPV4 Q9HBA0 1/20 0.39
ADORA2A P29274 3/20 0.32
ADORA1 P30542 3/20 0.32
PRKACA P17612 1/20 0.31
PRKACG P22612 1/20 0.31
PRKACB P22694 1/20 0.31
ADORA2B P29275 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153023 0.82 TRPV4 (0.42) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL9790158 0.78 ALDH1A1 (0.44) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL7042635 0.77 KHK (0.44) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL31314216 0.75 KHK (0.39) ALDH1A1MEN1KMT2AKHKTRPV4
SCHEMBL5704367 0.75 KMT2A (0.41) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL14408183 0.75 ALDH1A1 (0.41) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL8873189 0.72 GAA (0.36) ALDH1A1SMN1; SMN2CYP3A4GAA
SCHEMBL7557637 0.72 MEN1 (0.38) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL7557630 0.72 ALDH1A1 (0.38) ALDH1A1HPGDSMN1; SMN2MEN1TP53
SCHEMBL7038698 0.72 CASP1 (0.39) ALDH1A1HPGDSMN1; SMN2MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1319656-B1 A NEW PROCESS FOR PREPARING A QUINOLONE-CARBOXYLIC ACID LYNCHEM CO LTD (CN) 2006-08-23 EP disclosed
US-6699992-B2 REACTING M-FLUOROACETOPHENONE COMPOUND WITH ALKYL CARBONATE; REACTING ESTER OBTAINED WITH ALKYL ORTHOFORMATE AND AMINE; CYCLIZATION IN BASE LYNCHEM CO., LTD. (CN) 2004-03-02 US disclosed
US-20030166936-A1 Process for preparing a quinolone-carboxylic acid LYNCHEM CO., LTD. (CN) 2003-09-04 US disclosed
EP-1319656-A1 A NEW PROCESS FOR PREPARING A QUINOLONE-CARBOXYLIC ACID Lynchem Co., Ltd. (CN) 2003-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166936-A1 Process for preparing a quinolone-carboxylic acid CYP4B1, QPCT, NQO2 ALDH1A1 95/4885HPGD 1033/4885SMN1; SMN2 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.